Skip to main content
NCBI home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1993 Jan;142(1):95–105.

Coordinate synthesis of stromelysin, interleukin-1, and oncogene proteins in experimental osteoarthritis. An immunohistochemical study.

J P Pelletier 1, M P Faure 1, J A DiBattista 1, S Wilhelm 1, D Visco 1, J Martel-Pelletier 1
PMCID: PMC1886822  PMID: 8424468

Abstract

Metalloproteases appear to play an important role in the pathophysiology of osteoarthritis (OA) and their expression is believed to be regulated by cytokines such as interleukin-1 (IL-1). Nuclear oncogene products are suggested as mediators through which IL-1 induces metalloprotease gene expression. Little data are available on the in vivo involvement of these agents in the pathophysiology of OA. This study examined by immunohistochemistry, using specific antibodies, the distribution of stromelysin, IL-1 alpha, IL-1 beta, and oncogene products (c-FOS, c-JUN, and c-MYC) in synovium and cartilage from normal and experimental canine models of OA. In the OA synovium, stromelysin and IL-1 were localized in the cytoplasm of superficial synovial lining cells, infiltrating mononuclear cells, and endothelial and smooth muscle cells of the blood vessels, whereas oncoproteins were detected predominantly in the synovial lining cells. Normal synovial membranes demonstrated low levels of specific staining in synovial lining cells with occasional staining of blood vessel cells for IL-1 alpha, IL-1 beta, and stromelysin. In OA cartilage, chondrocytes at the superficial and middle layers as well as in fibrillated areas were found to be involved in the synthesis of stromelysin, IL-1, and oncoproteins. Diffuse staining of stromelysin and IL-1 beta in OA cartilage matrix was also identified. In normal cartilage, only a few chondrocytes at the superficial layer showed a low level of antigens. These results demonstrate the in vivo concomitant cellular and/or matrical presence of stromelysin, IL-1, and oncogene proteins in tissues from experimentally induced OA with the most intense staining at the sites of cartilage erosion and synovial proliferation. These findings suggest that they may be involved in the pathophysiology of OA, and that the regulatory mechanisms involved in the expression of these proteins may be associated.

Full text

PDF
95

Images in this article

98Figure 1
on p.98
99Figure 2
on p.99
100Figure 3
on p.100
101Figure 4
on p.101
102Figure 5
on p.102
103Figure 6
on p.103

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Auble D. T., Brinckerhoff C. E. The AP-1 sequence is necessary but not sufficient for phorbol induction of collagenase in fibroblasts. Biochemistry. 1991 May 7;30(18):4629–4635. doi: 10.1021/bi00232a039. [DOI] [PubMed] [Google Scholar]
  2. Case J. P., Lafyatis R., Remmers E. F., Kumkumian G. K., Wilder R. L. Transin/stromelysin expression in rheumatoid synovium. A transformation-associated metalloproteinase secreted by phenotypically invasive synoviocytes. Am J Pathol. 1989 Dec;135(6):1055–1064. [PMC free article] [PubMed] [Google Scholar]
  3. Case J. P., Sano H., Lafyatis R., Remmers E. F., Kumkumian G. K., Wilder R. L. Transin/stromelysin expression in the synovium of rats with experimental erosive arthritis. In situ localization and kinetics of expression of the transformation-associated metalloproteinase in euthymic and athymic Lewis rats. J Clin Invest. 1989 Dec;84(6):1731–1740. doi: 10.1172/JCI114356. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Conca W., Kaplan P. B., Krane S. M. Increases in levels of procollagenase messenger RNA in cultured fibroblasts induced by human recombinant interleukin 1 beta or serum follow c-jun expression and are dependent on new protein synthesis. J Clin Invest. 1989 May;83(5):1753–1757. doi: 10.1172/JCI114077. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Dean D. D. Proteinase-mediated cartilage degradation in osteoarthritis. Semin Arthritis Rheum. 1991 Jun;20(6 Suppl 2):2–11. doi: 10.1016/0049-0172(91)90023-s. [DOI] [PubMed] [Google Scholar]
  6. Dodge G. R., Poole A. R. Immunohistochemical detection and immunochemical analysis of type II collagen degradation in human normal, rheumatoid, and osteoarthritic articular cartilages and in explants of bovine articular cartilage cultured with interleukin 1. J Clin Invest. 1989 Feb;83(2):647–661. doi: 10.1172/JCI113929. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. HE C. S., Wilhelm S. M., Pentland A. P., Marmer B. L., Grant G. A., Eisen A. Z., Goldberg G. I. Tissue cooperation in a proteolytic cascade activating human interstitial collagenase. Proc Natl Acad Sci U S A. 1989 Apr;86(8):2632–2636. doi: 10.1073/pnas.86.8.2632. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Haraoui B., Pelletier J. P., Cloutier J. M., Faure M. P., Martel-Pelletier J. Synovial membrane histology and immunopathology in rheumatoid arthritis and osteoarthritis. In vivo effects of antirheumatic drugs. Arthritis Rheum. 1991 Feb;34(2):153–163. doi: 10.1002/art.1780340205. [DOI] [PubMed] [Google Scholar]
  9. Herman J. H., Appel A. M., Hess E. V. Modulation of cartilage destruction by select nonsteroidal antiinflammatory drugs. In vitro effect on the synthesis and activity of catabolism-inducing cytokines produced by osteoarthritic and rheumatoid synovial tissue. Arthritis Rheum. 1987 Mar;30(3):257–265. doi: 10.1002/art.1780300303. [DOI] [PubMed] [Google Scholar]
  10. Hunter T. Cooperation between oncogenes. Cell. 1991 Jan 25;64(2):249–270. doi: 10.1016/0092-8674(91)90637-e. [DOI] [PubMed] [Google Scholar]
  11. Leizer T., Clarris B. J., Ash P. E., van Damme J., Saklatvala J., Hamilton J. A. Interleukin-1 beta and interleukin-1 alpha stimulate the plasminogen activator activity and prostaglandin E2 levels of human synovial cells. Arthritis Rheum. 1987 May;30(5):562–566. doi: 10.1002/art.1780300511. [DOI] [PubMed] [Google Scholar]
  12. Lin J. X., Vilcek J. Tumor necrosis factor and interleukin-1 cause a rapid and transient stimulation of c-fos and c-myc mRNA levels in human fibroblasts. J Biol Chem. 1987 Sep 5;262(25):11908–11911. [PubMed] [Google Scholar]
  13. MacNaul K. L., Chartrain N., Lark M., Tocci M. J., Hutchinson N. I. Discoordinate expression of stromelysin, collagenase, and tissue inhibitor of metalloproteinases-1 in rheumatoid human synovial fibroblasts. Synergistic effects of interleukin-1 and tumor necrosis factor-alpha on stromelysin expression. J Biol Chem. 1990 Oct 5;265(28):17238–17245. [PubMed] [Google Scholar]
  14. Martel-Pelletier J., Cloutier J. M., Pelletier J. P. Neutral proteases in human osteoarthritic synovium. Arthritis Rheum. 1986 Sep;29(9):1112–1121. doi: 10.1002/art.1780290909. [DOI] [PubMed] [Google Scholar]
  15. Martel-Pelletier J., Faure M. P., McCollum R., Mineau F., Cloutier J. M., Pelletier J. P. Plasmin, plasminogen activators and inhibitor in human osteoarthritic cartilage. J Rheumatol. 1991 Dec;18(12):1863–1871. [PubMed] [Google Scholar]
  16. Martel-Pelletier J., Pelletier J. P., Malemud C. J. Activation of neutral metalloprotease in human osteoarthritic knee cartilage: evidence for degradation in the core protein of sulphated proteoglycan. Ann Rheum Dis. 1988 Oct;47(10):801–808. doi: 10.1136/ard.47.10.801. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Matrisian L. M., Leroy P., Ruhlmann C., Gesnel M. C., Breathnach R. Isolation of the oncogene and epidermal growth factor-induced transin gene: complex control in rat fibroblasts. Mol Cell Biol. 1986 May;6(5):1679–1686. doi: 10.1128/mcb.6.5.1679. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. McCachren S. S. Expression of metalloproteinases and metalloproteinase inhibitor in human arthritic synovium. Arthritis Rheum. 1991 Sep;34(9):1085–1093. doi: 10.1002/art.1780340904. [DOI] [PubMed] [Google Scholar]
  19. McGuire M. B., Murphy G., Reynolds J. J., Russell R. G. Production of collagenase and inhibitor (TIMP) by normal, rheumatoid and osteoarthritic synovium in vitro: effects of hydrocortisone and indomethacin. Clin Sci (Lond) 1981 Dec;61(6):703–710. doi: 10.1042/cs0610703. [DOI] [PubMed] [Google Scholar]
  20. Murphy G., Cockett M. I., Stephens P. E., Smith B. J., Docherty A. J. Stromelysin is an activator of procollagenase. A study with natural and recombinant enzymes. Biochem J. 1987 Nov 15;248(1):265–268. doi: 10.1042/bj2480265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Nagase H., Enghild J. J., Suzuki K., Salvesen G. Stepwise activation mechanisms of the precursor of matrix metalloproteinase 3 (stromelysin) by proteinases and (4-aminophenyl)mercuric acetate. Biochemistry. 1990 Jun 19;29(24):5783–5789. doi: 10.1021/bi00476a020. [DOI] [PubMed] [Google Scholar]
  22. Okada Y., Konomi H., Yada T., Kimata K., Nagase H. Degradation of type IX collagen by matrix metalloproteinase 3 (stromelysin) from human rheumatoid synovial cells. FEBS Lett. 1989 Feb 27;244(2):473–476. doi: 10.1016/0014-5793(89)80586-1. [DOI] [PubMed] [Google Scholar]
  23. Okada Y., Takeuchi N., Tomita K., Nakanishi I., Nagase H. Immunolocalization of matrix metalloproteinase 3 (stromelysin) in rheumatoid synovioblasts (B cells): correlation with rheumatoid arthritis. Ann Rheum Dis. 1989 Aug;48(8):645–653. doi: 10.1136/ard.48.8.645. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Ollivierre F., Gubler U., Towle C. A., Laurencin C., Treadwell B. V. Expression of IL-1 genes in human and bovine chondrocytes: a mechanism for autocrine control of cartilage matrix degradation. Biochem Biophys Res Commun. 1986 Dec 30;141(3):904–911. doi: 10.1016/s0006-291x(86)80128-0. [DOI] [PubMed] [Google Scholar]
  25. Pelletier J. P., Martel-Pelletier J., Altman R. D., Ghandur-Mnaymneh L., Howell D. S., Woessner J. F., Jr Collagenolytic activity and collagen matrix breakdown of the articular cartilage in the Pond-Nuki dog model of osteoarthritis. Arthritis Rheum. 1983 Jul;26(7):866–874. doi: 10.1002/art.1780260708. [DOI] [PubMed] [Google Scholar]
  26. Pelletier J. P., Martel-Pelletier J. Evidence for the involvement of interleukin 1 in human osteoarthritic cartilage degradation: protective effect of NSAID. J Rheumatol Suppl. 1989 Aug;18:19–27. [PubMed] [Google Scholar]
  27. Pelletier J. P., Mineau F., Faure M. P., Martel-Pelletier J. Imbalance between the mechanisms of activation and inhibition of metalloproteases in the early lesions of experimental osteoarthritis. Arthritis Rheum. 1990 Oct;33(10):1466–1476. doi: 10.1002/art.1780331003. [DOI] [PubMed] [Google Scholar]
  28. Pelletier J. P., Roughley P. J., DiBattista J. A., McCollum R., Martel-Pelletier J. Are cytokines involved in osteoarthritic pathophysiology? Semin Arthritis Rheum. 1991 Jun;20(6 Suppl 2):12–25. doi: 10.1016/0049-0172(91)90024-t. [DOI] [PubMed] [Google Scholar]
  29. Revell P. A., Mayston V., Lalor P., Mapp P. The synovial membrane in osteoarthritis: a histological study including the characterisation of the cellular infiltrate present in inflammatory osteoarthritis using monoclonal antibodies. Ann Rheum Dis. 1988 Apr;47(4):300–307. doi: 10.1136/ard.47.4.300. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Sabiston C. P., Adams M. E. Production of catabolin by synovium from an experimental model of osteoarthritis. J Orthop Res. 1989;7(4):519–529. doi: 10.1002/jor.1100070409. [DOI] [PubMed] [Google Scholar]
  31. Schönthal A., Herrlich P., Rahmsdorf H. J., Ponta H. Requirement for fos gene expression in the transcriptional activation of collagenase by other oncogenes and phorbol esters. Cell. 1988 Jul 29;54(3):325–334. doi: 10.1016/0092-8674(88)90195-x. [DOI] [PubMed] [Google Scholar]
  32. Spencer C. A., Groudine M. Control of c-myc regulation in normal and neoplastic cells. Adv Cancer Res. 1991;56:1–48. doi: 10.1016/s0065-230x(08)60476-5. [DOI] [PubMed] [Google Scholar]
  33. Tiku K., Thakker-Varia S., Ramachandrula A., Tiku M. L. Articular chondrocytes secrete IL-1, express membrane IL-1, and have IL-1 inhibitory activity. Cell Immunol. 1992 Mar;140(1):1–20. doi: 10.1016/0008-8749(92)90172-l. [DOI] [PubMed] [Google Scholar]
  34. Wilhelm S. M., Collier I. E., Kronberger A., Eisen A. Z., Marmer B. L., Grant G. A., Bauer E. A., Goldberg G. I. Human skin fibroblast stromelysin: structure, glycosylation, substrate specificity, and differential expression in normal and tumorigenic cells. Proc Natl Acad Sci U S A. 1987 Oct;84(19):6725–6729. doi: 10.1073/pnas.84.19.6725. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Wilhelm S. M., Wunderlich D., Maniglia C. A., Eisen A. Z., Goldberg G. I. Primary structure and function of stromelysin/transin in cartilage matrix turnover. Matrix Suppl. 1992;1:37–44. [PubMed] [Google Scholar]
  36. Wood D. D., Ihrie E. J., Dinarello C. A., Cohen P. L. Isolation of an interleukin-1-like factor from human joint effusions. Arthritis Rheum. 1983 Aug;26(8):975–983. doi: 10.1002/art.1780260806. [DOI] [PubMed] [Google Scholar]
  37. Wood D. D., Ihrie E. J., Hamerman D. Release of interleukin-1 from human synovial tissue in vitro. Arthritis Rheum. 1985 Aug;28(8):853–862. doi: 10.1002/art.1780280804. [DOI] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES